THORACIC NEOPLASMS
Clinical trials for THORACIC NEOPLASMS explained in plain language.
Never miss a new study
Get alerted when new THORACIC NEOPLASMS trials appear
Sign up with your email to follow new studies for THORACIC NEOPLASMS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Last-Resort drug access opens for rare lung cancer patients
Disease control NO_LONGER_AVAILABLEThis program gives adults with advanced or spreading ROS1-positive non-small cell lung cancer access to taletrectinib when they cannot use approved treatments or join ongoing studies. It is for patients who, in their doctor's opinion, might benefit from the drug. The goal is to p…
Matched conditions: THORACIC NEOPLASMS
Sponsor: Nuvation Bio Inc. • Aim: Disease control
Last updated May 26, 2026 07:07 UTC
-
New combo therapy shows promise for common lung cancer mutation
Disease control OngoingThis study looks at how well the drug osimertinib combined with chemotherapy works as the first treatment for people with advanced EGFR-mutant non-small cell lung cancer. It involves 532 adults with stage IIIB, IIIC, or IV disease who have not had prior therapy. The goal is to me…
Matched conditions: THORACIC NEOPLASMS
Sponsor: AstraZeneca • Aim: Disease control
Last updated May 22, 2026 14:03 UTC
-
New lung biopsy tool tested in over 1,300 patients
Knowledge-focused OngoingThis study looks at how well the Ion Endoluminal System works in everyday medical practice for taking tissue samples from lung spots or nodules. About 1,300 adults who need a lung biopsy or lesion localization will be observed. The goal is to see how often the system correctly di…
Matched conditions: THORACIC NEOPLASMS
Sponsor: Intuitive Surgical • Aim: Knowledge-focused
Last updated May 26, 2026 07:07 UTC
-
Can doctor training boost lung cancer care in smaller cities?
Knowledge-focused OngoingThis study looks at whether educating doctors in small and mid-sized city hospitals about standard guidelines helps improve testing and treatment for people with advanced non-small cell lung cancer. About 1000 patients will be observed to see if more get the right molecular tests…
Matched conditions: THORACIC NEOPLASMS
Sponsor: AstraZeneca • Aim: Knowledge-focused
Last updated May 26, 2026 06:53 UTC